SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-072770
Filing Date
2024-06-18
Accepted
2024-06-18 15:28:34
Documents
2
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2417329-14_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2417329-14_3seq1.xml 3 1636
2 EXHIBIT 24 tm2417329d14_ex24.htm EX-24 10438
  Complete submission text file 0001104659-24-072770.txt   13751
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Issuer) CIK: 0000884121 (see all company filings)

IRS No.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
SIC: 0000

Mailing Address C/O ABRDN 1900 MARKET STREET, SUITE 200 PHILADELPHIA PA 199103
Business Address
Taggart Michael (Reporting) CIK: 0002026676 (see all company filings)

Type: 3 | Act: 34 | File No.: 811-06565 | Film No.: 241051316